Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Total Net Revenue $ 2,763,202 $ 1,605,196
Total Cost of Sales 1,776,640 1,054,234
Gross Profit 986,562 550,962
Operating Expenses:    
Research and development 486,626 438,780
Selling, general and administrative 1,323,049 1,276,903
Depreciation and amortization 16,931 16,915
Total Operating Expenses 1,826,606 1,732,598
Operating loss (840,044) (1,181,636)
Other (Expenses) Income:    
Interest (expense), net (5,560) (2,530)
Total Other (Expense) (5,560) (2,530)
Loss before Provision (Benefit) for Income Taxes (845,604) (1,184,166)
Provision (Benefit) for Income Taxes 0 0
Net loss attributable to common stockholders $ (845,604) $ (1,184,166)
Net loss per common share:    
Basic - net income (loss) attributable to common stockholders $ (0.01) $ (0.01)
Diluted - net income (loss) attributable to common stockholders $ (0.01) $ (0.01)
Weighted Average Common Shares Outstanding- basic 134,793,211 133,695,111
Weighted Average Common Shares Outstanding - diluted 134,793,211 133,695,111
Product [Member]    
Total Net Revenue $ 2,586,669 $ 1,503,658
Total Cost of Sales 1,690,598 994,237
Recurring [Member]    
Total Net Revenue 176,533 101,538
Total Cost of Sales $ 86,042 $ 59,997